← Eichor
Study identifier: NCT04366804 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

International Validation of Two Non-motor Scales in PD (NFS and SPARK)

Condition: Parkinson's Disease · Non-motor Symptoms  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhaseN/A
Planned participants300
Who can joinAll sexes, 30 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).

This description comes directly from the study's public registry record.

Talk to the study team

Ines Debove, MD  ·  +41 31 63 2 79 24  ·  ines.debove@insel.ch

Always discuss trial participation with your own doctor first.

Locations (8)

Centre hospitalier régional universitaire de BesançonBesançon, FranceCompleted
Universitätsklinikum Carl Gustav CarusDresden, GermanyCompleted
Aristotle University of ThessalonikiThessaloniki, GreeceCompleted
Transilvania UniversityBrasov, RomaniaRecruiting
Hospital Universitario BurgosBurgos, SpainCompleted
Ruber International HospitalMadrid, SpainCompleted
Insel Gruppe AG University Hospital BernBern, SwitzerlandCompleted
King's College LondonLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04366804